explore -WSS

explore

author：entertainment 2025-10-01 21:35:28 - browse：9

Miniatures sit and stand on coin stacks that lined up from the tallest to the shortest — hospitals coverage from STAT — Adobe

Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby Boomers is keeping people in doctor’s offices, and health care providers are continuing to build capacity post-Covid.

Those trends — the same ones that tanked health insurance stocks a few weeks ago — made a strong mark on nonprofit health systems’ first quarter financial reports. STAT took a look at 20 large nonprofit health systems and found that all but four reported higher operating and net margins in the first three months of 2024 compared with the same period in 2023. Hospitals are seeing more patients and cutting down on the expensive contract labor they relied on during the Covid-19 pandemic. And they’re seeing strong investment gains on the non-operating side.

Volumes are just part of hospitals’ broader strategy to improve margins over the past few years, said Rick Kes, a health care partner with tax and consulting firm RSM. That includes things like fighting insurance denials and getting better deals from vendors for key supplies like drugs and medical devices.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Risky weight loss products often used by teens globally, per study

WSS

The SUPPORT Act is critical to fighting the opioid crisis

U.K. officials, researchers try to ease path for bespoke genetic treatments

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Doulas covered by Medicaid under New York's new plan

'Patient friction coefficient' can gauge a clinical trial's patient burden

New menopause drug shows promise in relief for hot flashes

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Walensky prepares to leave CDC — and Congress — behind

As JPM 2024 winds down, some health tech firms project optimism

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Supreme Court strikes down use of affirmative action

Mirador, a new biotech startup, launches with $400 million

Peter Hotez and the public health issue of online harassment

GSK to buy asthma

Peter Hotez and the public health issue of online harassment

Health and fitness trackers are measuring the wrong things

hotspot

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Cancer, immunology, HIV research ensnared in fetal tissue politics

This gene therapy has record $4.25 million price. It's saved children.

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

GSK to buy asthma

Testing GLP

focus

Wikipedia

focus

hotspot